| 摘要: |
| 目的:运用中药现代研究方法探讨中药对药“麻黄-半夏”治疗支气管哮喘的机制。方法:通过中药系统药理数据库与分
析平台(TCMSP)、DisGeNET 及GeneCards 检索“麻黄-半夏”的活性成分及作用靶点和支气管哮喘疾病靶点;利用STRING 11. 0
数据库获得蛋白相互作用( PPI) 网络;通过MetaScape 软件进行基因本体论( GO) 富集分析和京都基因与基因组百科全书
(KEGG)通路富集分析,得到“麻黄-半夏”对支气管哮喘的潜在作用通路;采用AutoDockTools、PyMOL 软件将主要的活性成分与
核心靶点进行对接。结果:从“麻黄-半夏”中筛选得到35 个活性成分,241 个靶点,其中涉及支气管哮喘作用靶点110 个,最终
筛选出9 个核心化合物和7 个核心靶点。KEGG 分析提示,“麻黄-半夏”可能通过磷脂酰肌醇3 激酶-蛋白激酶B(PI3K-Akt)、
白细胞介素(IL)-17、肿瘤坏死因子(TNF)等信号通路发挥对支气管哮喘的治疗作用,分子对接验证亦显示靶点与成分的结合
活性均较好。结论:“麻黄-半夏”治疗支气管哮喘具有“多成分-多靶点-多通路”的作用特点,预测“麻黄-半夏”可通过减少血管
内皮增生、抑制平滑肌细胞增殖、减轻炎症反应等治疗支气管哮喘,可为后续深入试验研究及其临床应用提供思路及方法。 |
| 关键词: 支气管哮喘 麻黄 半夏 网络药理学 分子对接 |
| DOI：doi:10.13407/j.cnki. jpp.1672-108X.2024.08.002 |
|
| 基金项目:基金项目:河南省自然科学基金,编号232300421188;河南省中医药科学研究专项课题,编号2022ZY1072。 |
|
| Mechanism of “Ephedra Herba-Pinellia Ternata” in the Treatment of Bronchial Asthma Based on NetworkPharmacology and Molecular Docking |
| Wang Zitong1, Zhu Shan2, Liu Ruijuan1, Niu Yongqing1 ( |
| (1. College of Pediatrics, Henan University of Chinese Medicine,
Zhengzhou 450000, China; 2. the Second Affiliated Hospital to Henan University of Chinese Medicine, Zhengzhou 450002, China) |
| Abstract: |
| Objective: To probe into the mechanism of “Ephedra herba-Pinellia ternata” in the treatment of bronchial asthma based on
network pharmacology and molecular docking. Methods: The chemical components and potential drug targets of “Ephedra herba-Pinellia
ternata” and bronchial asthma targets were searched from Traditional Chinese Medicine Systems Pharmacology Database and Analysis
Platform (TCMSP), DisGeNET and GeneCards database. STRING 11. 0 database was used to obtain protein-protein interaction (PPI)
network. Gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were carried out
by MetaScape software to obtain the potential pathway of “Ephedra herba-Pinellia ternata” on bronchial asthma. AutoDockTools and
PyMOL software were used to dock the main active components with the core targets. Results: Totally 35 active components and 241
targets were extracted from “Ephedra herba-Pinellia ternata”, of which 110 targets were related to the action of bronchial asthma, and
finally 9 core compounds and 7 core targets were screened out. KEGG enrichment analysis indicated that “Ephedra herba-Pinellia
ternata” may acted on bronchial asthma through phosphatidylinositol 3-kinase-protein kinase B (PI3K-Akt), interleukin (IL)-17, tumor
necrosis factor (TNF) and other signal pathways. Molecular docking results showed that the binding activity of targets and components
were good. Conclusion: The treatment of bronchial asthma with “Ephedra herba-Pinellia ternata” is characterized by “multicomponentmultitarget-
multipathway”, and it is predicted that the treatment of bronchial asthma with “Ephedra herba-Pinellia ternata” can be
achieved by decreasing the endothelial hyperplasia, inhibiting the proliferation of smooth muscle, and reducing the inflammatory
response, which can provide ideas and methods for the subsequent in-depth experimental research and clinical application. |
| Key words: bronchial asthma Ephedra herba Pinellia ternata network pharmacology molecular docking |
